(Q72005652)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653481%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

editorial

0 references

title

Etidronate in the management of glucocorticoid-induced osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653481%20AND%20SRC:MED&resulttype=core&format=json

glucocorticoid-induced osteoporosis

22 October 2019

main subject

1 reference

B P Lukert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653481%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 September 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653481%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

22 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653481%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653481%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653481%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

233-234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653481%20AND%20SRC:MED&resulttype=core&format=json

Steroid-induced fractures and bone loss in patients with asthma

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980153-3

Effects of hydrochlorothiazide and dietary sodium restriction on calcium metabolism in corticosteroid treated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980153-3

Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980153-3

Glucocorticoid Potentiation of the Adenosine 3′,5′- Monophosphate Response to Parathyroid Hormone in Cultured Rat Bone Cells*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980153-3

Bone histomorphometry in glucocorticoid-induced osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980153-3

Effect of glucocorticoids on bone resorption in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980153-3

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980153-3

Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980153-3

Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980153-3

Interpreting trials of bone-active agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980153-3

Two-year follow-up of biphosphonate (APD) treatment in steroid osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980153-3

10.1016/S0002-9343(99)80153-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7653481%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference